ADVANCE trial results suggest that intensive glucose control slows progression to ESRD in diabetic patients. PDF Print
Med Page Today: Over a mean follow up of five years, those on intensive glucose control had a significant 65% decreased risk of ESRD, compared with those on standard glucose-lowering therapy, Sophia Zoungas, MD, PhD, of the University of Sydney in Australia, reported during an oral session at the European Association for the Study of Diabetes meeting here.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.